A Phase 1 study of<scp>ADI‐PEG20</scp>(pegargiminase) combined with cisplatin and pemetrexed in<scp>ASS1‐negative</scp>metastatic uveal melanoma-Reference-Cited by-同舟云学术

A Phase 1 study ofADI‐PEG20(pegargiminase) combined with cisplatin and pemetrexed inASS1‐negativemetastatic uveal melanoma

Published:2022-05-16 Issue:4 Volume:35 Page:461-470
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res

Author:

Chan Pui Ying¹²^ORCID,Phillips Melissa M.¹,Ellis Stephen¹,Johnston Amanda³,Feng Xiaoxing³,Arora Amit⁴,Hay Gordon⁴,Cohen Victoria M. L.⁴,Sagoo Mandeep S.⁴⁵,Bomalaski John S.³,Sheaff Michael T.⁶,Szlosarek Peter W.¹⁷

Affiliation:

1. Department of Medical Oncology St Bartholomew's Hospital, Barts Health NHS Trust London UK

2. Wellcome Sanger Institute, Hinxton Cambridgeshire UK

3. Polaris Pharmaceuticals Inc San Diego California USA

4. Department of Ocular Oncology, Moorfields Eye Hospital Moorfields Eye Hospital NHS Foundation Trust London UK

5. NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and University College London Institute of Ophthalmology London UK

6. Department of Histopathology, Royal London Hospital Barts Health NHS Trust London UK

7. Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute Queen Mary University of London London UK

Funder

Higher Education Funding Council for England

Cancer Research UK

Moorfields Eye Hospital NHS Foundation Trust

Queen Mary University of London

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcmr.13042

Reference52 articles.

1. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

2. Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging

3. A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases

4. Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies

5. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities for nanomaterials in enzyme therapy;Journal of Controlled Release;2024-08

2. Causal relationship between genetically determined plasma metabolites and skin cancer: a two-sample Mendelian randomization study;Archives of Dermatological Research;2024-05-24

3. Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants;Molecular Cell;2024-05

4. Arginase-induced cell death pathways and metabolic changes in cancer cells are not altered by insulin;Scientific Reports;2024-02-19

5. Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment;International Journal of Molecular Sciences;2023-06-26